Details of the Drug

General Information of Drug (ID: DMLKI2B)

Drug Name
Trafermin
Synonyms Fiblast; Fiblast (TN); Trafermin (genetical recombination); Trafermin (USAN/INN); Trafermin (genetical recombination) (JAN)
Indication
Disease Entry ICD 11 Status REF
Periodontitis DA0C Phase 3 [1]
ATC Code
D03AX15: Trafermin
D03AX: Other cicatrizants
D03A: CICATRIZANTS
D03: PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS
D: DERMATOLOGICALS
Cross-matching ID
UNII
333OX80X87
DrugBank ID
DB06244
TTD ID
D0KV1Q

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fibroblast growth factor receptor 2 (FGFR2) TTGJVQM FGFR2_HUMAN Activator [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Periodontitis
ICD Disease Classification DA0C
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Fibroblast growth factor receptor 2 (FGFR2) DTT FGFR2 4.82E-01 -0.03 -0.2
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Emerging drugs for diabetic foot ulcers. Expert Opin Emerg Drugs. 2006 Nov;11(4):709-24.